Repligen Corporation (RGEN) stock news · rev $738.3M
Repligen Corporation (RGEN) is a medical instruments & supplies company listed on NASDAQ.
This RGEN news page leads with what Repligen Corporation filed — not a scraped headline mill.
No cached 8-K sentence for RGEN yet. We will not pad this page with generic market recap.
Latest reported RGEN revenue for 2025-12-31 was $738.3M. Net income was $48.9M. Revenue was up 16.4% from 2024-12-31 to 2025-12-31. RGEN currently screens at market cap $7.43B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the RGEN stock page; for the tape open the quote page.
RGEN stock news FAQ
What are RGEN's latest revenue and net income?
Latest cached Repligen Corporation (RGEN) revenue for Dec 31, 2025 was $738.3M. Net income was $48.9M. Statements: https://lician.com/financials/rgen
How did RGEN revenue change from the prior cached period?
Cached Repligen Corporation (RGEN) revenue was up 16.4% from $634.4M (Dec 31, 2024) to $738.3M (Dec 31, 2025). Statements: https://lician.com/financials/rgen
What is RGEN's market cap?
Repligen Corporation (RGEN) market cap is $7.43B on the latest cached fundamentals snapshot.
What kind of company is RGEN?
Repligen Corporation (RGEN) is a medical instruments & supplies company listed on NASDAQ.
Where is RGEN stock news listed?
Cached stock news for Repligen Corporation (RGEN) is listed at https://lician.com/news/rgen. Filings: https://lician.com/sec/rgen
Not investment advice.